Skip to main content

Table 5 Serum fatty acid profile of dogs fed diets supplemented with silybin and commercial hepatoprotectant (EXP1)

From: Effects of silybin supplementation on nutrient digestibility, hematological parameters, liver function indices, and liver-specific mi-RNA concentration in dogs

FA (g/100 g FA)

CON

(n = 18)

mean

HEP

(n = 18)

mean

SIL

(n = 18)

mean

SEM

P

C14:0

0.25

0.20

0.24

0.01

NSD

C15:0

0.08b

0.13a

0.10ab

0.01

0.02

C16:0

11.4

11.5

1.8

0.24

NSD

C17:0

0.30b

0.39a

0.34ab

0.01

0.04

C18:0

17.2

17.7

18.4

0.25

NSD

C20:0

0.18

0.22

0.19

0.01

NSD

C22:0

1.27a

0.84b

1.11a

0.06

<  0.001

C23:0

0.01

0.01

0.01

0.001

NSD

C24:0

0.03

0.03

0.03

0.001

NSD

C14:1

0.04

0.04

0.03

0.001

NSD

C15:1

0.12

0.12

0.11

0.01

NSD

C16:1

1.15

1.33

1.19

0.08

NSD

C17:1

0.16

0.14

0.14

0.01

NSD

C18:1 t 9

0.11

0.10

0.12

0.01

NSD

C18:1 t 11

0.28

0.29

0.32

0.01

NSD

C18:1 cis 9

11.4

11.2

11.4

0.42

NSD

C20:1 trans

0.06

0.06

0.07

0.01

NSD

C22:1 n9

0.33

0.24

0.30

0.02

NSD

C18:2 c 9 c 12

25.7

27.4

27.2

0.47

NSD

C18:3 c 9 c 12 c 15

0.64

0.79

0.83

0.04

NSD

C18:3 n6

0.04

0.04

0.05

0.001

NSD

C20:2

0.16

0.14

0.16

0.01

NSD

C20:3 n6

19.0

17.7

16.8

0.50

NSD

C20:4 n6

0.02

0.02

0.02

0.001

NSD

C20:5 n3

0.99a

0.58b

0.54b

0.06

<  0.001

C22:5 n3

2.01

2.72

2.30

0.13

NSD

C22:6 n3

0.04

0.04

0.04

0.01

NSD

Others

9.79

8.09

9.30

SUM

100

100

100

1SFA

31.6

31.5 (1.30)

32.6 (2.10)

0.43

NSD

2UFA

68.4

68.5 (1.30)

67.4 (2.10)

0.43

NSD

3MUFA

19.7

18.9 (.96)

19.2 (1.15)

0.45

NSD

4PUFA

48.5

49.4

48.0

0.71

NSD

n-6

45.0

45.3

44.4

0.63

NSD

n-3

3.68

4.12

3.71

0.13

NSD

n6/n3

12.4

11.0

12.3

0.37

NSD

n6 PUFA

44.7

45.2

44.1

0.63

NSD

n3 PUFA

3.68

4.12

3.71

0.13

NSD

PUFA/SFA

1.55

1.57

1.48

0.04

NSD

LNA/LA

41.8

34.9

34.6

1.92

NSD

5MCFA

13.2

13.4

12.7

0.30

NSD

6LCFA

86.6

86.4

87.1

0.31

NSD

  1. Abbreviations: CON, control group; HEP, group fed diet supplemented with commercial hepatoprotectant containing silybin; SIL, group fed diet supplemented with pure silybin; SFA, saturated fatty acids; UFA, unsaturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; MCFA, medium chain fatty acids; LCFA, long chain fatty acids; NSD, not statistically different
  2. Superscripts a,b in the same row indicate significant differences between control versus treatment groups (P <  0.05)